Stock Events

Stock Events

Stablecoin Development 

$1.46
94
+$0.15+11.03% Tuesday 19:54

Statistics

Day High
1.46
Day Low
1.29
52W High
99.75
52W Low
1.11
Volume
83,116
Avg. Volume
-
Mkt Cap
157.75M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Sep 25
$4
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

7NovExpected
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q3 2025
-1.15
-0.77
-0.38
-0
Expected EPS
-1.05
Actual EPS
-1.15

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SDEV. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ocular Therapeutix
OCUL
Mkt Cap2.05B
Ocular Therapeutix focuses on developing treatments for eye diseases, directly competing with Novabay's eye care products.
National Vision
EYE
Mkt Cap1.87B
National Vision Holdings operates in the eye care market, offering products that can be seen as alternatives to Novabay's offerings.
Alcon
ALC
Mkt Cap37.03B
Alcon specializes in eye care products, including surgical, vision care, and ophthalmic pharmaceuticals, competing across several of Novabay's key areas.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its Vision Care division, competes in the eye health sector, offering products that rival Novabay's.
Pfizer
PFE
Mkt Cap149.77B
Pfizer has a broad range of healthcare products, including treatments for eye conditions that compete with Novabay's pharmaceuticals.
Novartis
NVS
Mkt Cap279.67B
Novartis offers a wide range of healthcare products, including ophthalmic solutions that compete with Novabay's eye care products.
Bausch Health Companies
BHC
Mkt Cap2.11B
Bausch Health Companies, through its eye health division, directly competes with Novabay in the ophthalmology and optometry markets.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals is involved in developing treatments for eye diseases, offering products that compete with Novabay's portfolio.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, having acquired Allergan, competes in the eye care sector with a portfolio that includes treatments for various eye conditions, challenging Novabay's market share.

About

Stablecoin Development Corp. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Show more...
CEO
Mr. Michael Kazley
Employees
4
Country
United States
ISIN
US66987P5089

Listings

STU
DE
B9P1.STU
XASE
US
SDEV
MU
DE
B9P1.MU
XASE
US
NBY

0 Comments

Share your thoughts

FAQ

What is Stablecoin Development stock price today?▼
The current price of SDEV is $1.46 USD — it has increased by +11.03% in the past 24 hours. Watch Stablecoin Development stock price performance more closely on the chart.
What is Stablecoin Development stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Stablecoin Development stocks are traded under the ticker SDEV.
What is Stablecoin Development market cap?▼
Today Stablecoin Development has the market capitalization of 157.75M
What were Stablecoin Development earnings last quarter?▼
SDEV earnings for the last quarter are -1.15 USD per share, whereas the estimation was -1.05 USD resulting in a -9.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
Does Stablecoin Development pay dividends?▼
Yes, SDEV dividends are paid en. The last dividend per share was 4 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Stablecoin Development have?▼
As of May 06, 2026, the company has 4 employees.
In which sector is Stablecoin Development located?▼
Stablecoin Development operates in the Other sector.
When did Stablecoin Development complete a stock split?▼
The last stock split for Stablecoin Development was on February 23, 2026 with a ratio of 1:5.
Where is Stablecoin Development headquartered?▼
Stablecoin Development is headquartered in Emeryville, United States.